Ambivalent statements from health authority agencies seem to be slowing conversions from cigarettes to comparably healthier vaping and heated tobacco products.
Combating the illicit trade in opioids is important, as is trying to prevent overdoses, but the patients who require these medicines must not be lost in the cracks.
Thomas Miller warns against letting the perfect be the enemy of the good and offers his thoughts on a few recent reforms.
Vaping products should be regulated by the FDA, but a rush to regulation will harm smokers who use the products to quit.
In hopes of combating the ongoing opioid crisis, the US Surgeon General issued a national advisory urging more Americans to carry and know how to use naloxone, a drug which can save the lives of people overdosing on opioids. Experts discuss the merits of the advisory, as well as other steps necessary to fight the epidemic.
The United States Surgeon General issued a national advisory announcement yesterday urging Americans to carry and know how to use naloxone. AEI’s Sally Satel, MD, who is also a practicing addiction psychiatrist, cautions that naloxone alone is not enough to fight the opioid crisis. In her recent piece, Dr. Satel identifies three “medication-assisted treatments” that can lead to long-term success for opioid abusers: methadone, burprenorphine, and naltrexone.
The Centers for Medicare and Medicaid (CMS) has just released a Medicare rule that hardens accessibility of opioids. The implications could worsen functionality in those who have been dependent on these pharmaceuticals. Dr. Satel is available to comment on the CMS’ final Medicare rule, as well as the outlook for the opioid epidemic and ways to combat it.
Join AEI for remarks from Sen. Mike Lee (R-UT)and a panel discussion on “The Numbers Behind the Opioid Crisis,” a report from the Social Capital Project of the Joint Economic Committee.
Setting a rigid upper limit on dose demonstrates a failure to understand the complexities opioid pain management and will do little to address the current drug crisis while doing real harm to pain patients.
List prices for the most common Medicare drugs were found to have risen at nearly 10 times the inflation rate over the last five years. But as usual, we are all fixated on the wrong price.